Buprenorphine X-waiver exemption - beyond the basics for the obstetrical provider.

Cleary, Erin M; Smid, Marcela C; Charles, Jasmin E; Jones, Kaitlyn M; Costantine, Maged M; Saade, George; Rood, Kara M

Cleary, Erin M; Smid, Marcela C; Charles, Jasmin E; Jones, Kaitlyn M; Costantine, Maged M; Saade, George; Rood, Kara M.

Affiliation

Cleary EM; Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, The Ohio State University College of Medicine, Columbus, OH. Electronic address: ErinClearyMD@gmail.com.
Smid MC; Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of Utah Health, Salt Lake City, UT.
Charles JE; Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of Utah Health, Salt Lake City, UT.
Jones KM; College of Nursing, University of Utah Health, Salt Lake City, UT.
Costantine MM; Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, The Ohio State University College of Medicine, Columbus, OH.
Saade G; Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, TX.
Rood KM; Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, The Ohio State University College of Medicine, Columbus, OH.

Am J Obstet Gynecol MFM ; 3(6): 100451, 2021 11.

Article de En | MEDLINE | ID: mdl-34320429

Sujet(s)
Mots clés

buprenorphine X-waiver; opioid use disorder; perinatal addiction

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Médecins / Buprénorphine / Troubles liés aux opiacés Type d'étude: Guideline Limites: Humans Langue: En Journal: Am J Obstet Gynecol MFM Année: 2021 Type de document: Article Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google